ARCHIVES

Study: Ibrutinib Lowers IgM, Bone Marrow Disease Burden

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

ASCO Defines Clinically Meaningful Outcomes

April 25, 2013

DCT Board Approves Concepts For Three Radiation Research RFAs

March 6, 1987

PET Better At Evaluating Response In Sarcoma

February 29, 2008

Proteomics Promises Ways To Track Response To Therapy

April 25, 2003

Treatment Division Outlines Future Program Areas

January 24, 1975

HHS Approves Six State Plans To Insure Women With Cancer

June 8, 2001